BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11273141)

  • 1. Detection of anti-nuclear antibodies from filter paper blood clots using indirect immunoenzyme technique: preliminary experience and results.
    Chopra A; Anuradha V; Edmonds J
    J Assoc Physicians India; 2000 May; 48(5):493-6. PubMed ID: 11273141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antinuclear antibodies, patterns and characteristics obtained by immunofluorescence. The importance of the IgA, IgM and IgG isotypes].
    Arcavi M; Dadone J
    Medicina (B Aires); 2009; 69(5):502-6. PubMed ID: 19897433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
    Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
    J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
    Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
    Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of anti-DFS70 autoantibodies.
    Kang SY; Lee WI; Kim MH; La Jeon Y
    Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
    Homburger HA; Cahen YD; Griffiths J; Jacob GL
    Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect immunofluorescent assay for antinuclear antibodies on McCoy-Plovdiv serum-free cell line substrate.
    Zagorov MY; Draganov MM; Alimanska SA; Staykova ND; Stefanov RS; Trayancheva M; Kuzmanova SI; Murdjeva MA
    Comp Immunol Microbiol Infect Dis; 2007 May; 30(3):153-62. PubMed ID: 17241662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the LIAISON ANA screen assay for antinuclear antibody testing in autoimmune diseases.
    Ghillani P; Rouquette AM; Desgruelles C; Hauguel N; Le Pendeven C; Piette JC; Musset L
    Ann N Y Acad Sci; 2007 Aug; 1109():407-13. PubMed ID: 17785329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of antinuclear antibody connective tissue disease screen.
    López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
    Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of antineutrophil cytoplasmic antibodies in sera from patients with rheumatoid arthritis by indirect immunofluorescence technique].
    Nishiya K; Oohara E; Ooishi N; Moriki T; Kageoka T; Sasaki M; Hashimoto K
    Rinsho Byori; 1994 Feb; 42(2):176-82. PubMed ID: 8139127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
    Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
    Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
    Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
    Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
    J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
    Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
    Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and identification of significant ANAs in previously determined ANA negative samples.
    Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
    Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
    Myckatyn SO; Russell AS
    J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.